Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
ANIK

Anika Therapeutics (ANIK) stock: insider trades, news & valuation

Strong buying
Close · Oct 9, 2026 $19.58 +1.8% on the day +107.9% over 12 months 52-week range $9.02 – $22.03

Share price and insider trades

ANIK closeInsider buyInsider sale
510152025NovDecJan 2026FebMarAprMayJunJulAugSepOctEEarnings release filed 2025-11-05EEarnings release filed 2026-01-08EEarnings release filed 2026-02-26EEarnings release filed 2026-04-29EEarnings release filed 2026-07-29Bought $20,320 on 2026-08-04 · Gary P FischettiBought $20,750 on 2026-08-03 · Gary P FischettiBought $73,300 on 2026-05-01 · John B Henneman IIIBought $149,938 on 2026-04-30 · Stephen D. Griffin
Bought, 12 months$264K
Sold, 12 months$0
Insiders buying3
Insiders selling0

Anika Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 3 insiders bought $264K and 0 sold $0 of ANIK stock on the open market.

ANIK insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $223K bought (2 trades)$223KQ2 2026Q3 2026: $41K bought (2 trades)$41KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$41K2—0
Q2 2026$223K2—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.1×Last 5 sessions
Insiders' paper profit+$112KOn all tracked purchases +42.2%

Summary

Over the past 12 months, 3 Anika Therapeutics, Inc. insiders reported open-market purchases totaling $264K, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, John B Henneman III (Director) has the highest Insider Score at 68.

ANIK earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Jul 29, 2026 -3.9% None +19.3%S&P +0.1% +16.8%
Apr 29, 2026 +2.5% None -18.4%S&P +1.0% +16.7%
Feb 26, 2026 +5.9% None +31.3%S&P -1.0% -0.6%
Jan 8, 2026 +4.8% None -3.3%S&P +0.7% +9.9%
Nov 5, 2025 -0.2% None +1.2%S&P -0.7% -1.5%
Jul 30, 2025 -3.2% None -26.0%S&P -0.5% +13.6%
May 9, 2025 +4.6% None -19.6%S&P +3.2% -4.6%
Mar 12, 2025 -3.7% None -9.4%S&P -0.8% -10.3%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 5SEC Gary P FischettiDirector Buy 1,00053,015 held (+2%) $20.75 $21K -5.6% —
Aug 5SEC Gary P FischettiDirector Buy 1,00054,015 held (+2%) $20.32 $20K -3.6% —
May 4SEC John B Henneman IIIDirector Buy 5,00054,871 held (+10%) $14.66 $73K +33.6% 68
Apr 30SEC Stephen D. GriffinCEO, President Buy 12,20036,163 held (+51%) $12.29 $150K +59.3% —

Insiders at Anika Therapeutics, Inc.

InsiderBoughtSoldLast filingScore
Stephen D. GriffinCEO, President $150K — Apr 30, 2026 —
John B Henneman IIIDirector $73K — May 4, 2026 68
Gary P FischettiDirector $41K — Aug 5, 2026 —

ANIK stock: common questions

Are Anika Therapeutics, Inc. insiders buying ANIK stock?

In the past 12 months, 3 insiders reported open-market purchases of ANIK worth $264K. The latest was Director Gary P Fischetti bought $21K of ANIK at $20.75 — first open-market purchase in our records.

Are Anika Therapeutics, Inc. insiders selling ANIK stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ANIK's 52-week range?

Over the past year ANIK has traded between $9.02 and $22.03. It last closed at $19.58 on Oct 9, 2026.